Radioimmunoassay Market Application (Medical Diagnosis and Scientific Research), End-User (Biotechnology & Pharmaceutical Industry, Contract Research Organizations, Academic Research Institute, and Hospitals), and Product (Analyzers and Reagents & Kits): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 01-Dec-2020 Category: Technology & Media Report Format : PDF Pages: 110 Report Code: ZMR-831 Status : Published

According to the report published by Zion Market Research, global demand for Radioimmunoassay market was valued at approximately USD 392.41 Million in 2019, and is expected to generate revenue of around USD 474.02 Million by end of 2026, growing at a CAGR of around 3.48% between 2020 and 2026.

Description

According to the report published by Zion Market Research, global demand for Radioimmunoassay market was valued at approximately USD 392.41 Million in 2019, and is expected to generate revenue of around USD 474.02 Million by end of 2026, growing at a CAGR of around 3.48% between 2020 and 2026.

Global Radioimmunoassay Market: Overview

The estimation of certain protein in a complex mixture is an important input in the domain of medical science. In immunoassays, highly specific antibodies are used to target the specific molecule of interest and evaluate its quantity in a mixture. Radioimmunoassay is a medical diagnostic process used to quantify the number of specific antigens by using specific antibodies. Radioimmunoassay is a very sensitive technique, in which any biological molecule can be quantified if a specific antibody against it exists even in a very small amount.

Global Radioimmunoassay Market: Growth Factors

The increasing incidence of various infectious diseases and cancer is the major factor boosting the growth of the radioimmunoassay market. The other major factors propelling the growth of the global market include the rising usage of radioimmunoassay procedures in contract research organizations, pharmaceutical industries, and research centers and increasing demand for automated and high-throughput procedures in diagnostic labs and research centers to assure patients contentment in receiving fault-free outcomes. The global radioimmunoassay market is also anticipated to observe a noteworthy rate of growth in the near future due to high use these techniques in improvements in medical research and cancer detection.

Global Radioimmunoassay Market: Segmentation

The global radioimmunoassay market can be segmented based on application, end-user, product, and region. The application segment of the global market is sub-segmented into medical diagnosis and scientific research. The end-user segment of the global market is divided into biotechnology and pharmaceutical industry, contract research organizations, academic research institute, and hospitals. The product segment of the global radioimmunoassay market is diversified into analyzers and reagents & kits.

Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global Radioimmunoassay Market: Regional Analysis

Europe is anticipated to dominate the global radioimmunoassay market in the near future due to increasing frequency of various infectious diseases, increasing clinical trials, the high elderly population with cancer signs, and developments in medical research. North America is also expected to grow at a faster pace in the coming period. The factors such as increasing number of cancer patients, acceptance of enhanced technologies in research domain, and steadily rising alertness contribute in boosting the global radioimmunoassay market growth in this region. The rising expenditure on the development of research centers by the nongovernment and government organization may also propel the market growth in North America. Increasing use of radioimmunoassay techniques for diagnosis of cancer and the aging population may lead the Asia Pacific region to grow at a significant rate in the global market in the near future.

Global Radioimmunoassay Market: Competitive Players

Some main participants of the Radioimmunoassay market are Beckman Coulter, Inc., DIAsource ImmunoAssays SA, PerkinElmer, Inc., IBL International, and DRG International, Inc. The other key players in the global market are MP Biomedicals, LLC, Stratec Biomedical AG, Euro Diagnostica AB, Izotop, EMD Millipore, Berthold Technologies GmbH & Co. KG, and Cisbio, among others.

Radioimmunoassay Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodulogy
    • 2.1.Research Methodulogy
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Radioimmunoassay Market, 2016 – 2026 (USD Million)
    • 3.2.Global Radioimmunoassay Market: Snapshot
  • Chapter 4.Radioimmunoassay Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Radioimmunoassay
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technulogy Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Radioimmunoassay Market Attractiveness, By Application
    • 5.2.Global Radioimmunoassay Market Attractiveness, By End-User
    • 5.3.Global Radioimmunoassay Market Attractiveness, By Product
    • 5.4.Global Radioimmunoassay Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Radioimmunoassay Market: Company Market Share, 2019
    • 6.2.Strategic Developments
    • 7.1.Global Radioimmunoassay Market Overview: by Application
      • 7.1.1.Global Radioimmunoassay Market Revenue Share, by Application, 2019 & 2026
    • 7.2.Global Radioimmunoassay Market Analysis/Overview – By Application
      • 7.2.1.Medical Diagnosis – Overview/Analysis
      • 7.2.2.Scientific Research – Overview/Analysis
    • 7.3.Medical Diagnosis
      • 7.3.1.Global Radioimmunoassay Market for Medical Diagnosis, Revenue (USD Million) 2016 - 2026
    • 7.4.Scientific Research
      • 7.4.1.Global Radioimmunoassay Market for Scientific Research, Revenue (USD Million) 2016 - 2026
    • 8.1.Global Radioimmunoassay Market Overview: by End-User
      • 8.1.1.Global Radioimmunoassay Market Revenue Share, by End-User, 2019 & 2026
    • 8.2.Global Radioimmunoassay Market Analysis/Overview – By End-User
      • 8.2.1.Biotechnulogy & Pharmaceutical Industry – Overview/Analysis
      • 8.2.2.Contract Research Organizations – Overview/Analysis
      • 8.2.3.Academic Research Institute – Overview/Analysis
      • 8.2.4.Hospitals – Overview/Analysis
    • 8.3.Biotechnulogy & Pharmaceutical Industry
      • 8.3.1.Global Radioimmunoassay Market for Biotechnulogy & Pharmaceutical Industry, Revenue (USD Million) 2016 - 2026
    • 8.4.Contract Research Organizations
      • 8.4.1.Global Radioimmunoassay Market for Contract Research Organizations, Revenue (USD Million) 2016 - 2026
    • 8.5.Academic Research Institute
      • 8.5.1.Global Radioimmunoassay Market for Academic Research Institute, Revenue (USD Million) 2016 - 2026
    • 8.6.Hospitals
      • 8.6.1.Global Radioimmunoassay Market for Hospitals, Revenue (USD Million) 2016 - 2026
    • 9.1.Global Radioimmunoassay Market Overview: by Product
      • 9.1.1.Global Radioimmunoassay Market Revenue Share, by Product, 2019 & 2026
    • 9.2.Global Radioimmunoassay Market Analysis/Overview – By Product
      • 9.2.1.Analyzers – Overview/Analysis
      • 9.2.2.Reagents & Kits – Overview/Analysis
    • 9.3.Analyzers
      • 9.3.1.Global Radioimmunoassay Market for Analyzers, Revenue (USD Million) 2016 - 2026
    • 9.4.Reagents & Kits
      • 9.4.1.Global Radioimmunoassay Market for Reagents & Kits, Revenue (USD Million) 2016 - 2026
  • Chapter 10.Radioimmunoassay Market – Regional Analysis
    • 10.1.Global Radioimmunoassay Market: Regional Overview
      • 10.1.1.Global Radioimmunoassay Market Revenue Share, by Region, 2019 & 2026
      • 10.1.2.Global Radioimmunoassay Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 10.2.North America
      • 10.2.1.North America Radioimmunoassay Market Revenue, 2016 - 2026 (USD Million)
      • 10.2.2.North America Radioimmunoassay Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.2.3.North America Radioimmunoassay Market Revenue, by Application, 2016 – 2026
      • 10.2.4.North America Radioimmunoassay Market Revenue, by End-User, 2016 – 2026
      • 10.2.5.North America Radioimmunoassay Market Revenue, by Product, 2016 – 2026
      • 10.2.6. U.S.
      • 10.2.7.Canada
    • 10.3.Europe
      • 10.3.1.Europe Radioimmunoassay Market Revenue, 2016 - 2026 (USD Million)
      • 10.3.2.Europe Radioimmunoassay Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.3.3.Europe Radioimmunoassay Market Revenue, by Application, 2016 – 2026
      • 10.3.4.Europe Radioimmunoassay Market Revenue, by End-User, 2016 – 2026
      • 10.3.5.Europe Radioimmunoassay Market Revenue, by Product, 2016 – 2026
      • 10.3.6.Germany
      • 10.3.7.France
      • 10.3.8. U.K.
      • 10.3.9.Italy
      • 10.3.10.Spain
      • 10.3.11.Rest of Europe
    • 10.4.Asia Pacific
      • 10.4.1.Asia Pacific Radioimmunoassay Market Revenue, 2016 - 2026 (USD Million)
      • 10.4.2.Asia Pacific Radioimmunoassay Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.4.3.Asia Pacific Radioimmunoassay Market Revenue, by Application, 2016 – 2026
      • 10.4.4.Asia Pacific Radioimmunoassay Market Revenue, by End-User, 2016 – 2026
      • 10.4.5.Asia Pacific Radioimmunoassay Market Revenue, by Product, 2016 – 2026
      • 10.4.6.China
      • 10.4.7.Japan
      • 10.4.8.India
      • 10.4.9.South Korea
      • 10.4.10.South-East Asia
      • 10.4.11.Rest of Asia Pacific
    • 10.5.Latin America
      • 10.5.1.Latin America Radioimmunoassay Market Revenue, 2016 - 2026 (USD Million)
      • 10.5.2.Latin America Radioimmunoassay Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.5.3.Latin America Radioimmunoassay Market Revenue, by Application, 2016 – 2026
      • 10.5.4.Latin America Radioimmunoassay Market Revenue, by End-User, 2016 – 2026
      • 10.5.5.Latin America Radioimmunoassay Market Revenue, by Product, 2016 – 2026
      • 10.5.6.Brazil
      • 10.5.7.Mexico
      • 10.5.8.Rest of Latin America
    • 10.6.The Middle-East and Africa
      • 10.6.1.The Middle-East and Africa Radioimmunoassay Market Revenue, 2016 - 2026 (USD Million)
      • 10.6.2.The Middle-East and Africa Radioimmunoassay Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.6.3.The Middle-East and Africa Radioimmunoassay Market Revenue, by Application, 2016 – 2026
      • 10.6.4.The Middle-East and Africa Radioimmunoassay Market Revenue, by End-User, 2016 – 2026
      • 10.6.5.The Middle-East and Africa Radioimmunoassay Market Revenue, by Product, 2016 – 2026
      • 10.6.6.GCC Countries
      • 10.6.7.South Africa
      • 10.6.8.Rest of Middle-East Africa
  • Chapter 11.Company Profiles
    • 11.1.Beckman Coulter Inc.
      • 11.1.1.Company Overview
      • 11.1.2.Financial Overview
      • 11.1.3.Product Portfulio
      • 11.1.4.Business Strategy
      • 11.1.5.Recent Developments
    • 11.2.DIAsource ImmunoAssays SA
    • 11.3.PerkinElmer Inc.
    • 11.4.IBL International
    • 11.5.DRG International Inc.
    • 11.6.MP Biomedicals LLC
    • 11.7.Stratec Biomedical AG
    • 11.8.Euro Diagnostica AB
    • 11.9.Izotop
    • 11.1.EMD Millipore
    • 11.11.Berthuld Technulogies GmbH & Co. KG
    • 11.12.Cisbio
    • 11.13.Others

Methodology


Frequently Asked Questions

The increasing incidence of various infectious diseases and cancer is the major factor boosting the growth of the radioimmunoassay market.

According to Zion Market Research, global demand for Radioimmunoassay market is expected to generate revenue of around USD 474.02 Million by end of 2026, growing at a CAGR of around 3.48% between 2020 and 2026.

Europe is anticipated to dominate the global radioimmunoassay market in the near future due to increasing frequency of various infectious diseases, increasing clinical trials, the high elderly population with cancer signs, and developments in medical research.

Some main participants of the Radioimmunoassay market are Beckman Coulter, Inc., DIAsource ImmunoAssays SA, PerkinElmer, Inc., IBL International, and DRG International, Inc. The other key players in the global market are MP Biomedicals, LLC, Stratec Biomedical AG, Euro Diagnostica AB, Izotop, EMD Millipore, Berthold Technologies GmbH & Co. KG, and Cisbio, among others.
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social